CELG - Celgene Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 566.61B
Enterprise Value 377.39B
Trailing P/E 12.85
Forward P/E 17.64
PEG Ratio (5 yr expected) 10.60
Price/Sales (ttm)4.07
Price/Book (mrq)6.63
Enterprise Value/Revenue 34.73
Enterprise Value/EBITDA 69.19

Trading Information

Stock Price History

Beta (3Y Monthly) 1.50
52-Week Change 34.58%
S&P500 52-Week Change 30.90%
52 Week High 398.97
52 Week Low 358.59
50-Day Moving Average 392.99
200-Day Moving Average 392.69

Share Statistics

Avg Vol (3 month) 34.12M
Avg Vol (10 day) 32.64M
Shares Outstanding 5701.03M
Float 706.31M
% Held by Insiders 10.22%
% Held by Institutions 177.62%
Shares Short (Jul 31, 2019) 410.61M
Short Ratio (Jul 31, 2019) 42.76
Short % of Float (Jul 31, 2019) 41.51%
Short % of Shares Outstanding (Jul 31, 2019) 41.50%
Shares Short (prior month Jun 28, 2019) 49.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 26, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 32.23%
Operating Margin (ttm)47.47%

Management Effectiveness

Return on Assets (ttm)13.36%
Return on Equity (ttm)78.20%

Income Statement

Revenue (ttm)16.35B
Revenue Per Share (ttm)23.28
Quarterly Revenue Growth (yoy)15.40%
Gross Profit (ttm)14.06B
EBITDA 8.42B
Net Income Avi to Common (ttm)5.27B
Diluted EPS (ttm)7.32
Quarterly Earnings Growth (yoy)50.30%

Balance Sheet

Total Cash (mrq)9.32B
Total Cash Per Share (mrq)13.15
Total Debt (mrq)20.1B
Total Debt/Equity (mrq)199.95
Current Ratio (mrq)3.44
Book Value Per Share (mrq)14.19

Cash Flow Statement

Operating Cash Flow (ttm)7.91B
Levered Free Cash Flow (ttm)6.35B